Universal Health Services (UHS) Reports Q3 2026 Earnings Amid Mo
Universal Health Services (UHS) reported Q3 2026 earnings with adjusted EPS down 8% YoY to $5.22 and adjusted EBITDA declining to $625M. The company maintained its outlook but warned of potential lower-end results. UHS is trading at a 27.2% discount to its GF Value™ of $240.66, with a GF Score™ of 91, indicating strong fundamentals. GuruFocus highlights UHS's undervaluation and growth potential, while insider activity shows no purchases and $1.2M in sales.
How this was made
The 30-second read
Why it matters
The earnings decline may trigger short‑term selling, but the sizable valuation discount could attract value‑oriented investors.
Market read
UHS earnings miss is the primary market‑moving event; the article provides the first public disclosure of the Q3 numbers.
What to watch
Strong demand trends in acute care and behavioral health could support future earnings recovery.
Background
Universal Health Services is a $10.3B U.S.-based provider of inpatient psychiatric and acute care hospitals.
Ticker impact
UHS reported Q3 2026 adjusted EPS of $5.22, an 8% YoY decline, and EBITDA of $625M, both down from the prior year.
likely downward pressure as investors price in weaker earnings
The decline in EPS and EBITDA signals slower growth, and the guidance remains unchanged, which may not satisfy the market.
Market effects
Healthcare services sector may see modest pullback as a large peer shows earnings weakness.
U.S. hospital operators could face heightened scrutiny on margins.
Limited to U.S. healthcare investors; no broader macro effect.
Counterpoint
Valuation metrics suggest the stock is still 27% below intrinsic value, offering a buying opportunity despite the earnings miss.
Key entities
- companyUniversal Health Services
Operator of behavioral health and acute care facilities.




